IMR Press / FBL / Volume 13 / Issue 13 / DOI: 10.2741/3050

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Influenza vaccines
Show Less
1 Department of Infectious Diseases, St Jude Children’s Research Hospital, 332 N. Lauderdale, Memphis, TN 38105
2 Center for Biologic Evaluation and Research, Food and Drug Administration, 8800 Rockville Pike, Bethesda, MD 20892

*Author to whom correspondence should be addressed.

 

Front. Biosci. (Landmark Ed) 2008, 13(13), 4912–4924; https://doi.org/10.2741/3050
Published: 1 May 2008
Abstract

Influenza viruses pose a major challenge to those concerned with global public health. Not only do influenza viruses cause yearly epidemics that are associated with slight changes in viral antigenicity, but occasionally new viruses cross from animal reservoirs into humans causing major pandemics. The most effective method to lower the mortality and morbidity associated with influenza is vaccination. In this review current and pending influenza vaccine technologies will be discussed in the context of both epidemic and pandemic influenza.

Share
Back to top